ALZN - Alzamend Neuro Inc. Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati
Alzamend Neuro, Inc. (ALZN) kompaniyasining istiqbollari uning patentlarining ventura tabiati va sanoatning yirik ishtirokchilari tomonidan ko'rsatilayotgan kuchli bosim bilan cheklangan. Dorilarga bo'lgan barqaror talab xomashyo ta'minoti zanjiridagi uzilishlar xavfi bilan muvozanatlashgan. O'sish kompaniyalari uchun past baholanganlik metriki ushbu omillarning demensiyani davolash markazini yaratish bilan sinergiyasini vizuallashtiradi, bunda 0.00 aktiv qiymati va uning kengayish sur'ati o'rtasidagi muvozanatni belgilovchi joriy ko'rsatkich darajasi vazifasini o'taydi.
%20PEG%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_ALZN_-_Alzamend-Neuro-Inc._-_PEG-Multiple "ALZN - alzamend.com PEG multiplikatori 04.07.2022 - 13.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Alzamend Neuro, Inc. (ALZN) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi statistikasi:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Alzamend Neuro, Inc.|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi alzamend.com|ALZN - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Alzamend|ALZN - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Alzamend Neuro|Shoshilinch likvidlik koeffitsiyenti alzamend.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
ALZN - Sof foyda|Kutilayotgan sof foyda Alzamend Neuro, Inc.|ALZN - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori alzamend.com|ALZN - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Alzamend|ALZN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Alzamend Neuro|ALZN - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi alzamend.com|ALZN - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Alzamend Neuro, Inc.
Kompaniyaning umumiy tahlili:Alzamend Neuro Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN) uchun biznes barqarorligi Altsgeymer kasalligiga qarshi dori vositalarining klinik sinovlari muvaffaqiyati va barqaror daromadlilikka erishishdan oldin kapital jalb qilish qobiliyati bilan belgilanadi. PEG koeffitsiyentini tahlil qilish orqali investor bozor qiymatini sof foyda o'sish sur'atlari bilan solishtiradi, bunda birdan past qiymatlar aktivning istiqbollariga nisbatan fundamental past baholanganligidan dalolat beradi.
Alzamend Neuro, Inc. kimlar bilan raqobatlashadi
Narxning foydaga va o‘sish sur’atiga nisbati BIIB (Biogen Inc)|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|RGC (Regencell Corp) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Axsome Therapeutics - PEG multiplikatori|ACAD - PEG multiplikatori|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Viking Therapeutics Inc|SUPN (Supernus Pharma) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Catalyst Corp CPRX|Narxning foydaga va o‘sish sur’atiga nisbati Denali Therapeutics (DNLI)|harmonybiosciences.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BHVN (Biohaven)|AMLX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|TRVI: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Corp)|Anavex Life Sciences (AVXL) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CBLL|PRTA (Prothena Corporation plc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Alector Therapeutics ALEC|Narx-foyda va o‘sish multiplikatori ANNX (Annexon Inc.)|PEG multiplikatori omeros.com (OMER)|Narxning foydaga va o‘sish sur’atiga nisbati Neurogene Inc. NGNE|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACIU|VYGR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Neumora|SCLX (Scilex Holding Co.) - Narx-foyda va o‘sish multiplikatori|Tevogen Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ACOG (Alpha Cognition Inc) - PEG multiplikatori|cogrx.com (CGTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Inhibikase Therapeutics, Inc. (IKT)|Cassava Sciences Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ASRT (Assertio)|COYA - Narx-foyda va o‘sish multiplikatori|VTGN: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Ovid Therapeutics Inc. OVID|ABOS: PEG multiplikatori|CervoMed, Inc. (CRVO) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Alterity Therapeutics Ltd.|Narxning foydaga va o‘sish sur’atiga nisbati CLNN|Narx-foyda va o‘sish multiplikatori PEPG (PepGen Inc.)|JUNS: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GRCE - Narxning foydaga va o‘sish sur’atiga nisbati|AIFF (Firefly Neuro) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|KLTO: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NeuroSense Therapeutics Ltd. (NRSN)|Narx-foyda va o‘sish multiplikatori RVPH|PEG multiplikatori MetaVia, Inc.|Narxning foydaga va o‘sish sur’atiga nisbati NeurAxis, Inc (NRXS)|HSDT (heliusmedical.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Passage Bio PASG|Neuphoria Therapeutics, Inc. (NEUP) - O‘sish sur’atiga tuzatilgan narx-foyda|Minerva Neurosciences, Inc. - PEG multiplikatori|ATHA - PEG multiplikatori|Addex Therapeutics, Ltd. (ADXN) - Narxning foydaga va o‘sish sur’atiga nisbati|CYCN (Cyclerion Therapeutics, Inc.) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori PTIX|Pasithea - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori CRGT|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|CARA - Narx-foyda va o‘sish multiplikatori|Chromocell Therapeutics - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Eliem Therapeutics|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti LBPH|MRNS (Marinus) - PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti NKGN (NKGen Biotech Corp)|Narx-foyda va o‘sish multiplikatori NRBO (NeuroBo Pharmaceuticals)|SAGE (sagerx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Synaptogenix SNPX|TRVN: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Vigil Neuro - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Anew Medical Inc.|CERE (Cerevel Therapeutics) - Narx-foyda va o‘sish multiplikatori
